Phase II Study of S-1 Plus LV (1 Week on and 1 Week Off) as First-Line Treatment for Patients With Metastatic Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 17 Jan 2012
At a glance
- Drugs Folinic acid; Gimeracil/oteracil/tegafur
- Indications Colorectal cancer
- Focus Therapeutic Use
- 17 Jan 2012 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 17 Jan 2012 Actual patient number is 73 according to ClinicalTrials.gov.
- 17 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.